Key result
Shock Index-C > 10 linked to ~213% higher 1-year mortality following STEMI PCI.
Why the study?
Shock index is a simple prognostic tool in STEMI patients undergoing PCI, but an updated version including renal function was needed.
Does Shock Index-C (SIC) improve prediction of in-hospital events and mortality compared to standard Shock Index in patients with STEMI undergoing PCI?
Cohort (n=1,851)
No
Does Shock Index-C (SIC) improve prediction of in-hospital events and mortality compared to standard Shock Index in patients with STEMI undergoing PCI?
Hazard Ratio: 3.13 (95% CI 2.01–4.87)
p-value: p=<0.001
Shock Index-C, which incorporates renal function, provides superior risk stratification for in-hospital events and 1-year mortality compared to standard Shock Index in STEMI patients undergoing PCI.
May refine STEMI risk stratification after PCI; hypothesis-generating and requires prospective validation before any practice change.
Background: Shock index (heart rate/systolic blood pressure, SI) is a simple scale with prognostic value in patients with ST-segment elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI). The present study introduces an updated version of SI that includes renal function. Methods: A total of 1,851 consecutive patients with STEMI undergoing PCI were retrospectively included at Cardiac Care Unit in Guangdong Provincial People's Hospital and divided into two groups according to their admission time: derivation database (from January 2010 to December 2013, n = 1,145) and validation database (from January 2014 to April 2016, n = 706). Shock Index-C (SIC) was calculated as (SI × 100)–estimated CCr. Calibration was evaluated using the Hosmer-Lemeshow statistic. The predictive power of SIC was evaluated using receiver operating characteristic (ROC) curve analysis. Results: The predictive value and calibration of SIC for in-hospital death was excellent in derivation [area under the curve (AUC) = 0.877, p < 0.001; Hosmer-Lemeshow chi-square = 3.95, p = 0.861] and validation cohort (AUC = 0.868, p < 0.001; Hosmer-Lemeshow chi-square = 5.01, p = 0.756). SIC exhibited better predictive power for in-hospital events than SI (AUC: 0.874 vs. 0.759 for death; 0.837 vs. 0.651 for major adverse clinical events [MACEs]; 0.707 vs. 0.577 for contrast-induced acute kidney injury [CI-AKI]; and 0.732 vs. 0.590 for bleeding, all p < 0.001). Cumulative 1-year mortality was significantly higher in the upper SIC tertile (log-rank = 131.89, p < 0.001). Conclusion: SIC was an effective predictor of poor prognosis and may have potential as a novel and simple risk stratification tool for patients with STEMI undergoing PCI.
No takes yet. Share an insight, caveat, or question.
Ran et al. (2021) conducted a cohort in ST-segment elevation myocardial infarction (STEMI) (n=1,851). Shock Index-C (SIC) > 10 vs. Shock Index-C (SIC) ≤ 10 was evaluated on 1-year mortality (HR 3.13, 95% CI 2.01-4.87, p=<0.001). A Shock Index-C score > 10 was independently associated with a significantly higher risk of 1-year mortality (HR 3.13) in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: